Ischemic preconditioning phosphorylates mitogen-activated kinases and heat shock protein 27 in the diabetic rat heart

D Ebel1, O Toma, S Appler

  • 1Klinik für Anästhesiologie, Universitätsklinikum Düsseldorf, Düsseldorf, Germany. D.Ebel@ic.umcn.nl

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|September 24, 2008
PubMed

Insights

Diabetes mellitus blocks the protective effects of ischemic preconditioning (IPC) in rat hearts. This occurs downstream of mitogen-activated protein kinases and heat shock protein 27 signaling pathways.

Area of Science:

  • Cardiovascular Biology
  • Metabolic Disease Research
  • Cellular Signaling

Background:

  • Ischemic preconditioning (IPC) offers cardioprotection, but its efficacy is diminished in diabetes mellitus.
  • The underlying mechanisms by which diabetes impairs IPC remain largely unknown.

Purpose of the Study:

  • To investigate the impact of diabetes on IPC-induced cardioprotection in a rat model.
  • To examine the role of mitogen-activated protein kinases (MAPKs) and heat shock protein 27 (HSP27) phosphorylation in the diabetic heart's response to IPC.

Main Methods:

  • Nondiabetic and diabetic rats underwent IPC protocols (coronary artery occlusion/reperfusion).
  • Myocardial infarct size was measured after prolonged ischemia/reperfusion.
  • Western blot analysis was used to assess MAPK (ERK1/2, JNK, p38) and HSP27 phosphorylation levels in heart tissue.

Main Results:

  • IPC significantly reduced infarct size in nondiabetic rats but failed to provide protection in diabetic rats.
  • Despite the lack of protection, IPC induced phosphorylation of MAPKs and HSP27 in diabetic rat hearts.
  • Diabetes mellitus blocks IPC-induced cardioprotection without affecting MAPK or HSP27 phosphorylation.

Conclusions:

  • The protective mechanism of IPC is blocked by diabetes mellitus in the rat heart.
  • The blockade mechanism operates downstream of MAPK and HSP27 signaling pathways.

Related Concept Videos